For T cells, APS could apparently inhibit S100 sarcoma growth, increase CD4+ T cells expression and IL-2 production, and decrease CD8+ T cell and IL-4 levels in peripheral blood (Zou et al., 2012). Here, IL4 is linked to autoimmune polyendocrinopathy.